TABLE 2.

PRNT₅₀ titer against rMACV pre- or postchallenge

PRNT50 titer for the following groupa:
PBS treated		rCd#1 infected		rMACV/Cd#1-GPC infected		Uninfected
Prechallengeb	Postchallenge	Prechallenge	Postchallenge	Prechallenge	Postchallenge
<1:30	<1:30 (25)	<1:30	NAc (20)	1:120	1:240 (42)	<1:30
<1:30	<1:30 (22)	<1:30	<1:30 (18)	1:120	1:240 (42)	<1:30
<1:30	<1:30 (28)	<1:30	NA (29)	1:60	1:240 (42)	<1:30
<1:30	1:60 (42)	<1:30	1:960 (32)	1:120	1:240 (42)	<1:30
<1:30	1:30 (33)	<1:30	NA (13)	1:60	1:60 (42)
<1:30	<1:30 (39)	<1:30	1:480 (42)	1:30	1:960 (42)

^aNumbers in parentheses are the day after challenge.

^bPrechallenge serum was collected at 35 days after immunization.

^cNA, not available.